| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.7 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |